Early changes in extracellular matrix in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Aims: Although changes in extracellular matrix (ECM) scaffold have been reported previously in Alzheimer's disease (AD) compared to normal ageing, it is not known how alterations in the numerous components of the perivascular ECM might occur at different stages of AD. This study therefore investigates potential changes in basement membrane‐associated ECM molecules in relation to increasing Braak stages. Methods: Thirty patients were divided into three groups (control subject, subclinical AD and AD patients). ECM levels of collagen IV, perlecan and fibronectin as well as human platelet endothelial cell adhesion molecule (hPECAM) were quantified by immunohistochemistry. Von Willebrand factor staining was measured to assess vessel density. Expression levels were correlated with the presence of amyloid plaques. Results: Collagen IV, perlecan and fibronectin expression was increased in subclinical AD and AD patients when compared to controls, in frontal and temporal cortex, whilst no further increase was detected between subclinical AD and AD. These changes were not associated with an increase in vessel density, which was instead decreased in the temporal cortex of AD patients. In contrast, hPECAM levels remained unchanged. Finally, we found similar pattern in levels of amyloid deposition between the different Braak stages and showed that changes in ECM components correlated with amyloid deposition. Conclusion: Present data support the hypothesis that significant ECM changes occur during the early stages of AD. ECM changes affecting brain microvascular functions could therefore drive disease progression and provide potential new early investigational biomarkers in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
The extracellular matrix at a glance
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Crews, L., & Masliah, E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq160 · Cited by 772
Extracellular matrix molecules and synaptic plasticity
Dityatev, A., & Schachner, M. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1115 · Cited by 564
The dual role of the extracellular matrix in synaptic plasticity and homeostasis
Dityatev, A., Schachner, M., & Sonderegger, P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2898 · Cited by 559
Pathophysiology of the brain extracellular matrix: a new target for remyelination
Lau, L. W., Cua, R., Keough, M. B., Haylock-Jacobs, S., & Yong, V. W. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3550 · Cited by 549
Research works printed but not linked: 55
- 10.1002/jnr.22393 · DOI · Paper page
- 10.2174/156720510790691074 · DOI
- 10.1110/ps.04887005 · DOI
- 10.3109/13506120309041728 · DOI
- 10.1016/0306-3623(93)90350-7 · doi:10.1016/0306-3623(93)90350-7
- 10.2741/A277 · DOI · Paper page
- 10.1016/S1357-2725(03)00169-9 · DOI
- 10.1073/pnas.0408235102 · DOI · Paper page
- 10.1016/j.ydbio.2009.10.026 · DOI · Paper page
- 10.1091/mbc.11.9.3109 · DOI
- 10.1016/j.cub.2012.08.051 · DOI · Paper page
- 10.1016/j.ypmed.2012.01.003 · DOI
- 10.1016/j.tins.2010.08.003 · DOI · Paper page
- 10.1016/0006-8993(95)01250-8 · DOI
- 10.1007/s004010000195 · DOI · Paper page
- 10.3233/JAD-2004-6404 · DOI · Paper page
- 10.2174/156720508785132334 · DOI · Paper page
- Snow AD, 1990, Early accumulation of heparan sulfate in neurons and in the beta‐amyloid protein‐containing lesions of Alzheimer's disease and Down's syndrome, Am J Pathol, 137, 1253
- 10.1046/j.1471-4159.1996.67031132.x · DOI
- 10.1159/000252764 · DOI
- 10.3233/JAD-141266 · DOI · Paper page
- 10.1136/jcp.41.4.476 · doi:10.1136/jcp.41.4.476
- 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3 · doi:10.1002/(sici)1097-0215(20000115)85:2<281::aid-ijc21>3.0.co;2-3 · Paper page
- 10.1111/nan.12070 · DOI · Paper page
- 10.1523/JNEUROSCI.11-11-03679.1991 · DOI · Paper page
- 10.1007/s004010100414 · DOI
- 10.1016/S0002-9440(10)65529-0 · DOI
- 10.1016/S0197-4580(00)00121-4 · DOI · Paper page
- Snow AD, 1988, The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease, Am J Pathol, 133, 456
- 10.1523/JNEUROSCI.4031-05.2005 · DOI · Paper page
- 10.1111/j.1749-6632.1997.tb48467.x · DOI · Paper page
- 10.1007/s00702-004-0181-4 · DOI
- 10.1097/01.jnen.0000203077.53080.2c · DOI · Paper page
- 10.1016/j.neuropharm.2009.01.006 · DOI · Paper page
- 10.1055/s-0037-1613410 · doi:10.1055/s-0037-1613410
- 10.1016/S0006-8993(00)02769-4 · DOI
- 10.1017/S1041610210000827 · DOI · Paper page
- Mroczko B, 2014, Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease, J Alzheimers Dis, 40, 351, 10.3233/JAD-131634 · DOI · Paper page
- 10.1111/j.1750-3639.2008.00195.x · DOI · Paper page
- 10.1186/alzrt44 · DOI · Paper page
- 10.1016/j.neuroimage.2004.07.006 · DOI · Paper page
- 10.1007/BF00294434 · DOI
- 10.1148/radiology.178.1.1984287 · DOI · Paper page
- 10.1007/BF00690372 · DOI · Paper page
- 10.1017/S0317167100037124 · DOI
- 10.1007/BF00294246 · DOI · Paper page
- 10.1152/physrev.00035.2003 · DOI · Paper page
- 10.1007/s10522-010-9281-8 · DOI
- 10.1016/j.nbd.2006.11.011 · DOI · Paper page
- 10.1159/000343491 · DOI · Paper page
- 10.1016/j.yexcr.2004.08.002 · DOI
- 10.1007/s00401-006-0054-z · DOI
- 10.1016/S0002-9440(10)62993-8 · DOI · Paper page
- 10.1007/978-1-4939-0320-7_27 · doi:10.1007/978-1-4939-0320-7_27
- 10.1111/j.1468-1331.2006.01640.x · DOI · Paper page
Cited by
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
“A β peptides also cross BMECs to and from the brain by active transport, so the altered expression of A β peptide transporters in endothelial cells could contribute to the accumulation of A β (Zlokovic et al., 2010).”
The vascular basement membrane in the healthy and pathological brain
Thomsen, M. S., Routhe, L. J., & Moos, T. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17722436 · Cited by 490
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease
Yamazaki, Y., & Kanekiyo, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091965 · Cited by 451
“compared to controls, whereas no significant difference was detected between subclinical AD and AD cases [130].”
ResultBlood-brain barrier permeability and physical exercise
Małkiewicz, M. A., Szarmach, A., Sabisz, A., Cubała, W. J., Szurowska, E., & Winklewski, P. J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1403-x · Cited by 276
Zhang, Q., Ma, C., Gearing, M., Wang, P. G., Chin, L.-S., & Li, L. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0524-2 · Cited by 165
del Campo, M., Peeters, C. F. W., Johnson, E. C. B., Vermunt, L., Hok-A-Hin, Y. S., van Nee, M., Chen-Plotkin, A., Irwin, D. J., Hu, W. T., Lah, J. J., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00300-1 · Cited by 95
The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier
Magaki, S., Tang, Z., Tung, S., Williams, C. K., Lo, D., Yong, W. H., Khanlou, N., & Vinters, H. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.004 · Cited by 93
Basal lamina changes in neurodegenerative disorders
Nguyen, B., Bix, G., & Yao, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00502-y · Cited by 75
Molecular Networks and Key Regulators of the Dysregulated Neuronal System in Alzheimer’s Disease
Wang, M., Li, A., Sekiya, M., Beckmann, N. D., Quan, X., Schrode, N., Fernando, M. B., Yu, A., Zhu, L., Cao, J., et al. (2019) · doi:10.1101/788323 · Cited by 6
Adriaanse, B. A., Brady, S., Wang, M., Beard, D. J., Spencer, J. I., Pansieri, J., Sutherland, B. A., Esiri, M. M., Buchan, A. M., Cader, Z., et al. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12904 · Cited by 2
“Significant changes in ECM have been reported in the early stages of AD [41] and inhibiting hippocampal ECM changes restored both long-term potentiation and contextual memory performance in APP/PS1 transgenic mice [42].”
Background
Metadata
- Authors
- Lepelletier, F. ‐., Mann, D. M. A., Robinson, A. C., Pinteaux, E., & Boutin, H.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2015-11-30
- Volume
- 43
- Issue
- 2
- Pages
- 167-182
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W2146046417
- Cited by
- 198
- References
- 22
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Seventh Framework Programme (FP7/2007–2013, HEALTH‐F2‐2011‐278850 (INMiND))
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.